Review



biomarkers sst2  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    R&D Systems biomarkers sst2
    Biomarkers Sst2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biomarkers+sst2/Human+ST2%2FIL-33R+Quantikine+ELISA+Kit/us11708608-1323-1-8
    Average 95 stars, based on 61 article reviews
    biomarkers sst2 - by Bioz Stars, 2026-09
    95/100 stars

    Images

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Therapeutic and diagnostic methods for IL-33-mediated disorders
    Article Snippet: .. Methods Biomarkers sST2 was measured by ELISA (#DST200, R&D Systems, Quantikine). .. Serum periostin was measured by immunoassay using the ELECSYS® Periostin assay on the Cobas e601 analyzer (Roche Professional Diagnostics, Penzberg, Germany), as previously reported (Jia et al. J.



    Similar Products

    90
    Galectin Therapeutics sst2 biomarker
    Sst2 Biomarker, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biomarkers+sst2/galectin+3/pm40649060-5-9-16
    Average 90 stars, based on 1 article reviews
    sst2 biomarker - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    95
    R&D Systems biomarkers sst2
    Biomarkers Sst2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biomarkers+sst2/Human+ST2%2FIL-33R+Quantikine+ELISA+Kit/us11708608-1323-1-8
    Average 95 stars, based on 1 article reviews
    biomarkers sst2 - by Bioz Stars, 2026-09
    95/100 stars
      Buy from Supplier

    90
    Wolters Kluwer Health sst2 biomarker
    Sst2 Biomarker, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biomarkers+sst2/sst2+biomarker/10__1097_slash_tp__0000000000004447-94-2-54
    Average 90 stars, based on 1 article reviews
    sst2 biomarker - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Opfermann Arzneimittel GMBH sst2 biomarker
    Kaplan–Meier survival of patients with a normal or elevated pre-operative soluble suppression of tumorigenicity-2 <t>(sST2)</t> level.
    Sst2 Biomarker, supplied by Opfermann Arzneimittel GMBH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/biomarkers+sst2/lvad/med_rxiv__2023__02__06__23285564-20-8-0
    Average 90 stars, based on 1 article reviews
    sst2 biomarker - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Kaplan–Meier survival of patients with a normal or elevated pre-operative soluble suppression of tumorigenicity-2 (sST2) level.

    Journal: medRxiv

    Article Title: Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients

    doi: 10.1101/2023.02.06.23285564

    Figure Lengend Snippet: Kaplan–Meier survival of patients with a normal or elevated pre-operative soluble suppression of tumorigenicity-2 (sST2) level.

    Article Snippet: Opfermann et al. showed a significant increase in sST2 during the initial post-operative period after LVAD implantation and normalization to pre-operative levels after one week and normal levels after three weeks. ( ) Although repeated sST2 measurements appeared to be a strong predictor of outcome in patients with acute HF , the predictive value of serially measured sST2 levels in LVAD patients on long term outcomes has not been elucidated yet.

    Techniques:

    Trajectory of post-operative soluble suppression of tumorigenicity-2 (sST2) levels in four patients. The black dots indicate the sST2 measurement, and the predicted sST2 trajectory by the linear mixed effects model is depicted by the colored line for patients (A and B) without event (A and B) or patients that reached the primary endpoint (C and D).

    Journal: medRxiv

    Article Title: Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients

    doi: 10.1101/2023.02.06.23285564

    Figure Lengend Snippet: Trajectory of post-operative soluble suppression of tumorigenicity-2 (sST2) levels in four patients. The black dots indicate the sST2 measurement, and the predicted sST2 trajectory by the linear mixed effects model is depicted by the colored line for patients (A and B) without event (A and B) or patients that reached the primary endpoint (C and D).

    Article Snippet: Opfermann et al. showed a significant increase in sST2 during the initial post-operative period after LVAD implantation and normalization to pre-operative levels after one week and normal levels after three weeks. ( ) Although repeated sST2 measurements appeared to be a strong predictor of outcome in patients with acute HF , the predictive value of serially measured sST2 levels in LVAD patients on long term outcomes has not been elucidated yet.

    Techniques:

    Heatmap for death or urgent heart transplantation (A) and right heart failure (B) of all post-operative soluble suppression of tumorigenicity-2 (sST2) levels, sorted by highest value. The triangle (▼) indicates urgent heart transplantation, the circle (Ο) indicates death and the asterisk (*) indicates right heart failure.

    Journal: medRxiv

    Article Title: Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients

    doi: 10.1101/2023.02.06.23285564

    Figure Lengend Snippet: Heatmap for death or urgent heart transplantation (A) and right heart failure (B) of all post-operative soluble suppression of tumorigenicity-2 (sST2) levels, sorted by highest value. The triangle (▼) indicates urgent heart transplantation, the circle (Ο) indicates death and the asterisk (*) indicates right heart failure.

    Article Snippet: Opfermann et al. showed a significant increase in sST2 during the initial post-operative period after LVAD implantation and normalization to pre-operative levels after one week and normal levels after three weeks. ( ) Although repeated sST2 measurements appeared to be a strong predictor of outcome in patients with acute HF , the predictive value of serially measured sST2 levels in LVAD patients on long term outcomes has not been elucidated yet.

    Techniques: Transplantation Assay

    Journal: medRxiv

    Article Title: Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients

    doi: 10.1101/2023.02.06.23285564

    Figure Lengend Snippet:

    Article Snippet: Opfermann et al. showed a significant increase in sST2 during the initial post-operative period after LVAD implantation and normalization to pre-operative levels after one week and normal levels after three weeks. ( ) Although repeated sST2 measurements appeared to be a strong predictor of outcome in patients with acute HF , the predictive value of serially measured sST2 levels in LVAD patients on long term outcomes has not been elucidated yet.

    Techniques: